🇺🇸 FDA
Pipeline program

PF-07868489

C5001004

Phase 2 small_molecule active

Quick answer

PF-07868489 for Pulmonary Arterial Hypertension is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer Ireland Pharmaceuticals Unlimited Company
Indication
Pulmonary Arterial Hypertension
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials